[1]
Pawar, A. et al. 2022. Formulation and In-vitro Evaluation of Gliclazide and Nimodipine Bilayer Tablets for the Treatment of Type II Diabetes Mellitus and Hypertension. International Journal of Pharmaceutical Sciences and Nanotechnology(IJPSN). 15, 3 (May 2022), 5936–5945. DOI:https://doi.org/10.37285/ijpsn.2022.15.3.2.